← Leaderboards
Rasmus Skaarup Mortensen
Statens Serum Institute
$3,235,534
Attributed
$3,235,534
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,235,534 · 2
By mechanism
R01$3,235,534 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Tuberculosis”
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Yunda Huang · Fred Hutchinson Cancer Center$52,438,893
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$31,845,607
- Jay Evans · University Of Montana$15,453,274
Research focus
TuberculosisSafetyMycobacterium TuberculosisT-LymphocyteVaccinesTuberculosis VaccinesInfectionLeadProgramsSubunit VaccinesVaccinationVaccine CandidateImmune ResponseVaccinologyDesignGlobal Health EmergencyAntigensClinical TrialsPreventProductionResponseAdolescentBaseAnimal Model
Grant awards (4)
Dissecting the role of vaccine-promoted Th17 cells in protective immunity against tuberculosis$666,567
R01 · FY2025 · AI · contact PI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity$647,855
R01 · FY2022 · AI · contact PI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity$1,155,591
R01 · FY2021 · AI · contact PI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity$765,521
R01 · FY2020 · AI · contact PI